SPK-9001 was licensed by Pfizer from Spark Therapeutics pursuant to a December 2014 agreement, under which Spark was responsible for conducting all phase 1 and 2 studies for the gene therapy.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Compare To: SPK.AX Compare Select to analyze similar companies using key performance metrics; select up to 4 stocks. SPK.AX Spark New Zealand Limited 2.1100 +0.48% Mkt cap AUD 3.974B Industry Telecom ...

The script prints the defaults for the experiment config qm9_atomwise. The dataset will be downloaded automatically to spk_workdir/data, if it does not exist yet. Then, the training will be started.

You signed in with another tab or window. Reload to refresh your session. You signed out in another tab or window. Reload to refresh your session. You switched accounts on another tab or window.